Related Experiment Videos
[Visual prognosis in polypoidal choroidal vasculopathy associated with subretinal hematoma]
Tadaki Kimura1, Joe Akita, Kazuaki Nishijima
1Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto-shi, 606-8507, Japan.
Nippon Ganka Gakkai Zasshi
|November 8, 2002
Summary
Polypoidal choroidal vasculopathy (PCV) with subfoveal hemorrhage has a variable prognosis. Choroidal neovascularization (CNV) significantly impacts visual outcomes, highlighting the importance of early CNV detection for better prognosis in PCV patients.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Vascular Anomalies
Context:
- Polypoidal choroidal vasculopathy (PCV) is a subtype of age-related macular degeneration.
- Subfoveal hemorrhage in PCV can lead to poor visual acuity despite generally better prognoses than typical AMD.
- Understanding factors influencing visual recovery after hemorrhage is crucial for patient management.
Purpose:
- To evaluate factors affecting visual prognosis in eyes with subfoveal hematoma secondary to PCV.
- To determine the correlation between hematoma characteristics, choroidal neovascularization (CNV), and visual acuity outcomes.
Summary:
- Retrospective analysis of 15 eyes with PCV and subfoveal hematoma (>1 disc diameter).
- Hematoma area and absorption time did not correlate with visual prognosis.
- Association with CNV significantly impacted visual outcome; treatment did not restore vision in affected eyes.
Impact:
- CNV is a critical factor influencing the prognosis of PCV with subfoveal hemorrhage.
- Early detection of CNV is essential for predicting visual prognosis in PCV patients.
- Findings emphasize the need for targeted management strategies for PCV patients with CNV.